Literature DB >> 27960350

A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range.

Eric M Gale1, Chloe M Jones1, Ian Ramsay1, Christian T Farrar1, Peter Caravan1.   

Abstract

We introduce a new biochemically responsive Mn-based MRI contrast agent that provides a 9-fold change in relaxivity via switching between the Mn3+ and Mn2+ oxidation states. Interchange between oxidation states is promoted by a "Janus" ligand that isomerizes between binding modes that favor Mn3+ or Mn2+. It is the only ligand that supports stable complexes of Mn3+ and Mn2+ in biological milieu. Rapid interconversion between oxidation states is mediated by peroxidase activity (oxidation) and l-cysteine (reduction). This Janus system provides a new paradigm for the design of biochemically responsive MRI contrast agents.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27960350      PMCID: PMC5328420          DOI: 10.1021/jacs.6b10898

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  34 in total

1.  Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.

Authors:  Peter Caravan
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

2.  A mononuclear manganese(II) complex demonstrates a strategy to simultaneously image and treat oxidative stress.

Authors:  Meng Yu; Stephen L Ambrose; Zachary L Whaley; Sanjun Fan; John D Gorden; Ronald J Beyers; Dean D Schwartz; Christian R Goldsmith
Journal:  J Am Chem Soc       Date:  2014-09-04       Impact factor: 15.419

Review 3.  Redox-activated MRI contrast agents based on lanthanide and transition metal ions.

Authors:  Pavel B Tsitovich; Patrick J Burns; Adam M McKay; Janet R Morrow
Journal:  J Inorg Biochem       Date:  2014-01-30       Impact factor: 4.155

4.  A magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide.

Authors:  Meng Yu; Ronald J Beyers; John D Gorden; Justin N Cross; Christian R Goldsmith
Journal:  Inorg Chem       Date:  2012-08-13       Impact factor: 5.165

5.  Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.

Authors:  Michael O Breckwoldt; John W Chen; Lars Stangenberg; Elena Aikawa; Elisenda Rodriguez; Shumei Qiu; Michael A Moskowitz; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

Review 6.  Redox- and hypoxia-responsive MRI contrast agents.

Authors:  Quyen N Do; James S Ratnakar; Zoltán Kovács; A Dean Sherry
Journal:  ChemMedChem       Date:  2014-05-13       Impact factor: 3.466

7.  Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.

Authors:  Michael J DeLeo; Matthew J Gounis; Bo Hong; John C Ford; Ajay K Wakhloo; Alexei A Bogdanov
Journal:  Radiology       Date:  2009-06-22       Impact factor: 11.105

8.  Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

Authors:  Matthias Nahrendorf; David Sosnovik; John W Chen; Peter Panizzi; Jose-Luiz Figueiredo; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

9.  A Manganese Alternative to Gadolinium for MRI Contrast.

Authors:  Eric M Gale; Iliyana P Atanasova; Francesco Blasi; Ilknur Ay; Peter Caravan
Journal:  J Am Chem Soc       Date:  2015-12-04       Impact factor: 15.419

10.  Molecular-level functional magnetic resonance imaging of dopaminergic signaling.

Authors:  Taekwan Lee; Lili X Cai; Victor S Lelyveld; Aviad Hai; Alan Jasanoff
Journal:  Science       Date:  2014-05-02       Impact factor: 63.714

View more
  11 in total

1.  Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.

Authors:  Hao Li; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2019-10-17       Impact factor: 15.419

2.  Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex.

Authors:  Huan Wang; Veronica Clavijo Jordan; Ian A Ramsay; Mozhdeh Sojoodi; Bryan C Fuchs; Kenneth K Tanabe; Peter Caravan; Eric M Gale
Journal:  J Am Chem Soc       Date:  2019-03-28       Impact factor: 15.419

Review 3.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

Review 4.  Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.

Authors:  Pascal Röthlisberger; Cécile Gasse; Marcel Hollenstein
Journal:  Int J Mol Sci       Date:  2017-11-16       Impact factor: 5.923

5.  Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents.

Authors:  Christian E Anderson; Shannon B Donnola; Yun Jiang; Joshua Batesole; Rebecca Darrah; Mitchell L Drumm; Susann M Brady-Kalnay; Nicole F Steinmetz; Xin Yu; Mark A Griswold; Chris A Flask
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

Review 6.  Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation.

Authors:  Yewei Liu; Shuncong Wang; Xiaohui Zhao; Yuanbo Feng; Guy Bormans; Johan Swinnen; Raymond Oyen; Gang Huang; Yicheng Ni; Yue Li
Journal:  Diagnostics (Basel)       Date:  2020-01-31

7.  Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.

Authors:  Celia Martinez de la Torre; Jasmine H Grossman; Andrey A Bobko; Margaret F Bennewitz
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

Review 8.  Activatable Nanoparticles: Recent Advances in Redox-Sensitive Magnetic Resonance Contrast Agent Candidates Capable of Detecting Inflammation.

Authors:  Chukwuazam Nwasike; Erin Purr; Eunsoo Yoo; Jaspreet Singh Nagi; Amber L Doiron
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-16

9.  Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.

Authors:  Aohan Hu; Eduardo Aluicio-Sarduy; Victoria Brown; Samantha N MacMillan; Kaelyn V Becker; Todd E Barnhart; Valery Radchenko; Caterina F Ramogida; Jonathan W Engle; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2021-06-30       Impact factor: 16.383

10.  Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting.

Authors:  Christian E Anderson; Mette Johansen; Bernadette O Erokwu; He Hu; Yuning Gu; Yifan Zhang; Michael Kavran; Jason Vincent; Mitchell L Drumm; Mark A Griswold; Nicole F Steinmetz; Ming Li; Heather Clark; Rebecca J Darrah; Xin Yu; Susann M Brady-Kalnay; Chris A Flask
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.